Follow the people · Insider
Sean Saint
Sean Saint files insider transactions with the SEC as a president & ceo of Beta Bionics (BBNX). We hold 4 disclosed purchases and sales filed since 31 January 2025, 2 of them in the last 90 days.
- Files forBBNX
- Disclosed buys and sells4 in all, 2 in the last 90 days
- Last disclosure4 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 29 January 2025 — 3 September 2026President & CEO · Beta Bionics (BBNX)24 Form 4 lines · source: SEC Form 4
Everything they disclosed
24 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 5,641 shares of Beta BionicsSEC Form 44 September 2026Common Stock · traded 3 September 2026 · filed 4 September 2026
- ▼ sold on the open market 16,867 shares of Beta BionicsSEC Form 43 September 2026Common Stock · traded 2 September 2026 · filed 3 September 2026
- ▼ sold on the open market 16,872 shares of Beta BionicsSEC Form 43 June 2026Common Stock · traded 2 June 2026 · filed 3 June 2026
- was granted 287,944 shares of Beta Bionics (a derivative holding)SEC Form 413 March 2026Employee Stock Option (right to buy) · traded 27 February 2026 · filed 13 March 2026
- was granted 287,944 shares of Beta Bionics (a derivative holding)SEC Form 413 March 2026Employee Stock Option (right to buy) · traded 27 February 2026 · filed 13 March 2026
- was granted 343,269 shares of Beta BionicsSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- ▼ sold on the open market 3,384 shares of Beta BionicsSEC Form 43 March 2026Common Stock · traded 2 March 2026 · filed 3 March 2026
- was granted 184,837 shares of Beta Bionics (a derivative holding)SEC Form 43 March 2026Employee Stock Option (right to buy) · traded 27 February 2026 · filed 3 March 2026
- was granted 184,837 shares of Beta Bionics (a derivative holding)SEC Form 43 March 2026Employee Stock Option (right to buy) · traded 27 February 2026 · filed 3 March 2026
- was granted 343,269 shares of Beta BionicsSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- ▼ sold on the open market 3,384 shares of Beta BionicsSEC Form 43 March 2026Common Stock · traded 2 March 2026 · filed 3 March 2026
- ▼ sold on the open market 3,278 shares of Beta BionicsSEC Form 44 December 2025Common Stock · traded 2 December 2025 · filed 4 December 2025
- ▼ sold on the open market 3,359 shares of Beta BionicsSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- ▼ sold on the open market 943 shares of Beta BionicsSEC Form 44 June 2025Common Stock · traded 2 June 2025 · filed 4 June 2025
- ▼ sold on the open market 2,185 shares of Beta BionicsSEC Form 44 June 2025Common Stock · traded 2 June 2025 · filed 4 June 2025
- ▼ sold on the open market 311 shares of Beta BionicsSEC Form 44 June 2025Common Stock · traded 2 June 2025 · filed 4 June 2025
- was granted 163,000 shares of Beta Bionics (a derivative holding)SEC Form 43 March 2025Employee Stock Option (right to buy) · traded 27 February 2025 · filed 3 March 2025
- was granted 108,000 shares of Beta BionicsSEC Form 43 March 2025Common Stock · traded 27 February 2025 · filed 3 March 2025
- was granted 749,445 shares of Beta Bionics (a derivative holding)SEC Form 43 February 2025Employee Stock Option (right to buy) · traded 31 January 2025 · filed 3 February 2025
- was granted 83,268 shares of Beta Bionics (a derivative holding)SEC Form 43 February 2025Employee Stock Option (right to buy) · traded 31 January 2025 · filed 3 February 2025
- was granted 494,198 shares of Beta Bionics (a derivative holding)SEC Form 43 February 2025Employee Stock Option (right to buy) · traded 31 January 2025 · filed 3 February 2025
- was granted 54,911 shares of Beta Bionics (a derivative holding)SEC Form 43 February 2025Employee Stock Option (right to buy) · traded 31 January 2025 · filed 3 February 2025
- was granted 467,944 shares of Beta Bionics (a derivative holding)SEC Form 43 February 2025Employee Stock Option (right to buy) · traded 31 January 2025 · filed 3 February 2025
- was granted 467,944 shares of Beta Bionics (a derivative holding)SEC Form 431 January 2025Employee Stock Option (right to buy) · traded 29 January 2025 · filed 31 January 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.